Reference
Wang J, et al. Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databases. EClinicalMedicine 48: Jun 2022. Available from: URL: https://www.thelancet.com/journals/eclinm/issue/current
Rights and permissions
About this article
Cite this article
Multiple drugs. Reactions Weekly 1931, 392 (2022). https://doi.org/10.1007/s40278-022-27189-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-27189-4